Our results demonstrated that the phosphatidylinositol 3-kinase (PI3K)/AKT pathway participated in the GHK-induced upregulation of miR-146a-3p and miR-146a-3p/AQP4 interaction plays a role in the injury following ICH
The animals were first adapted to testing environment after a shortened pellet (10.3 cm), their usual diet, was administered in the cylinder
This can reduce breakage, split ends, and other forms of hair damage
GHK-Cu stands out as a versatile, biologically active compound with significant potential across various applications
Daily Protocol: 1-2 mg subcutaneous injection, administered at the same time each day Alternative Protocol: 2 mg subcutaneous injection, 3 times per week Cycle Length: 12-16 weeks minimum for hair applications Break Period: 4-6 weeks between cycles Time to First Results: Subtle scalp improvements at 4-8 weeks, visible density changes at 12-16 weeks Timing considerations favor consistency above specific scheduling
Minoxidil and GHK-Cu share VEGF upregulation but through different pathways (minoxidil via potassium channel/PHD inhibition, GHK-Cu via fibroblast stimulation)
